Akero Therapeutics, Inc. (AKRO)

NASDAQ

$54.65

+$0.00 (0.00%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$54.52$54.65

Open $54.52

52 Week Range

$21.34$58.40

Previous Close $54.65

Market Cap4.50B

Volume11.61M

Avg Volume2.56M

P/E (TTM)-15.31

EPS (TTM)$-3.57

Dividend / YieldN/A

Dividend StreakN/A

AKRO Financial Summary

Akero Therapeutics, Inc. (AKRO) reported revenue of $0 and net income of $-252.06M for FY 2024..

Period:

Financial Statements

Financial data for AKRO

Revenue

0.00% YoY

Net Income

-$252M

66.09% YoY

EPS

$-3.75

29.76% YoY

Margins

Gross:NaN%

Operating:-Infinity%

Net:-Infinity%

ROE:0.00%

Income Statement

Annual Income Statement for AKRO

Item	2024	2023	2022	2021	2020
Revenue	$0	$0	$0	$0	$0
Cost of Revenue	$0	$0	$0	$0	$213K
Gross Profit	$0	$0	$0	$0	-$213K
Operating Expenses	$285M	$173M	$115M	$101M	$80M
Operating Income	-$285M	-$173M	-$115M	-$101M	-$80M
Net Income	-$252M	-$152M	-$112M	-$101M	-$79M
EPS	$-3.75	$-2.89	$-2.87	$-2.89	$-2.52
EBITDA	-$247M	-$149M	-$111M	-$101M	-$79M